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Alcoholic hepatitis accelerates early 
hepatobiliary cancer by increasing 
stemness and miR-122-mediated 
HIF-1α activation
Aditya Ambade, Abhishek Satishchandran & Gyongyi Szabo
Alcohol-related hepatocellular carcinoma (HCC) develops with advanced alcoholic liver disease and 
liver fibrosis. Using adult mice, we evaluate the effect of alcoholic steatohepatitis on early hepatobiliary 
carcinoma after initiation by diethyl-nitrosamine (DEN). Here we show that alcohol-fed DEN-injected 
mice have higher ALT and liver-to-body weight ratio compared to pair-fed DEN-injected mice. Alcohol 
feeding results in steatohepatitis indicated by increased pro-inflammatory cytokines and fibrotic genes. 
MRI and liver histology of alcohol+DEN mice shows hepatobiliary cysts, early hepatic neoplasia and 
increase in serum alpha-fetoprotein. Proliferation makers (BrdU, cyclin D1, p53) and cancer stem cell 
markers (CD133 and nanog) are significantly up-regulated in livers of alcohol-fed DEN-injected mice 
compared to controls. In livers with tumors, loss of miR-122 expression with a significant up-regulation 
of miR-122 target HIF-1α is seen. We conclude that alcoholic steatohepatitis accelerates hepatobiliary 
tumors with characteristic molecular features of HCC by up-regulating inflammation, cell proliferation, 
stemness, and miR-122 loss.
Hepatocellular carcinoma (HCC) is the most common liver cancer, and worldwide it represents the fifth most 
common primary cancer1. HCC is also the third leading cause of cancer related mortality globally2. In the United 
States, the incidence of HCC has tripled over the last two decades3,4. Unlike many other cancers with known asso-
ciated risk factors, the underlying molecular pathophysiology for HCC is still not completely known. Most com-
monly, the incidence of HCC is linked to known risk factors including hepatitis B and C, aflatoxin and chronic 
alcohol consumption5. Each of these factors alone poses a significant risk to development of liver cirrhosis6. In 
fact, independent of the initial insult, cirrhosis remains the single common precursor of HCC development.
Hepatocarcinogenesis is a multistep, multistage process that involves genetic and epigenetic alterations that 
ultimately lead to malignant transformation of hepatocytes7. Several animal models have been reported that 
mimic different steps leading to HCC8; however, no animal model of alcohol-related HCC exists that represents 
human alcoholic liver with features of steatoheptitis and liver fibrosis. Chemically induced HCC models such as 
the N-nitrosodiethylamine (DEN) induced HCC model are the most widely used and accepted8. DEN acts as an 
alkylating agent for DNA bases which initiates the formation of neoplasms9. A recent study combined DEN with 
alcohol administration in the drinking water10; however this form of alcohol feeding fails to result in liver steatosis 
or inflammation that are characteristics of human alcoholic liver disease11. Human HCC is poorly understood, 
and molecular markers and checkpoints in HCC have recently received attention. It has been shown that the 
pro-inflammatory cell and cytokine environment, defects in cell proliferation and stem cell-mediated repair all 
contribute to the multistep process of HCC8,12,13.
In this study, we administered 6 doses of DEN to 4 week old adult C57bl/6 male mice followed by 6 weeks 
of Lieber-DeCarli alcohol diet. We report a synergistic effect of alcohol with DEN resulting in up-regulation of 
inflammatory and fibrotic markers and a remarkable induction of early hepatobiliary cancers in mice receiv-
ing alcohol-diet and DEN. At the molecular level, livers of alcohol-fed DEN-injected mice show significant 
up-regulation of markers of cell proliferation, stemness (CD133, nanog), as well as tissue inflammation and 
up-regulation of hypoxia inducible factor-1α and its target, VEGFR1. These results indicate that chronic alcohol 
accelerates hepatobiliary cancer via multiple key mechanisms in carcinogenesis.
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Figure 1. Alcohol and DEN are additive in induction of liver inflammation and fibrosis. (a) Tissue 
protein levels of pro-inflammatory cytokines (n ≥ 5mice per group). (b) Fold changes in mRNA levels of 
pro-inflammatory cytokines in liver tissue. (c) Serum ALT levels at sacrifice. (d) Liver tissue ROS measured 
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Results
Combination of alcohol and DEN induces sustained liver injury. Chronic alcohol use is a major 
risk factor for HCC development in humans4. Here we hypothesized that the alcoholic liver environment accel-
erates liver tumor development after repeated administration of a chemical carcinogen, DEN. In this study, male 
C57bl/6 mice received 6 weekly DEN injections, starting at age of 4 weeks followed by chronic alcohol admin-
istration (Supplementary Fig. S1). Chronic alcohol exposure induces inflammation that is driven by secretion 
of pro-inflammatory cytokines14. We analyzed TNFα , MCP-1, and IL-6 expression at the protein and mRNA 
levels in the liver tissue and observed that expression of these pro-inflammatory cytokines at the protein level 
was significantly higher in alcohol-fed DEN-injected mice as compared to pair-fed DEN-injected or alcohol-fed 
saline-injected mice (Fig. 1a). Interestingly, the expression of TNFα and IL-6 at the mRNA level in alcohol-fed 
DEN-injected mice was lower than alcohol-fed saline-injected mice (Fig. 1b). IL-17A is an inflammatory and 
immunoregulatory cytokine secreted by Th17 cells, γ δ T cells and has been recently reported to promote tumor 
growth in hepatocellular carcinoma15. While both alcohol and DEN, respectively increased IL-17A levels in our 
experimental model, IL-17A induction was additively increased by combination of DEN and alcohol in the liver 
at the tissue protein (Fig. 1a) and mRNA (Fig. 1b) levels, compared to pair-fed DEN-injected and alcohol-fed 
saline-injected mice. Serum ALT was significantly higher in alcohol-fed DEN-injected mice compared to any 
other group (Fig. 1c). Liver to body weight ratio at sacrifice was significantly higher in alcohol-fed DEN-injected 
mice as compared to alcohol-fed saline-injected and pair-fed DEN-injected mice (Supplementary Fig. S2). 
Alcohol induced oxidative stress as measured by thiobarbituric acid reactive substances (TBARS) was signifi-
cantly higher in alcohol-fed DEN-injected mice compared to other experimental groups (Fig. 1d).
HCC in human alcoholics develops in fibrotic and cirrhotic livers16. The Sirius Red staining suggested a higher 
degree of fibrosis in alcohol-fed DEN-injected mice compared to other groups (Fig. 1e,f). To estimate the extent 
of fibrosis, we evaluated α -SMA, procollagen1α and TGFβ expression in the liver. As shown in Fig. 1g, all mark-
ers of fibrosis were significantly up-regulated in alcohol-fed DEN-injected mice (Fig. 1g). These data indicated 
significant inflammation and fibrosis in our experimental model.
Alcohol accelerates HCC development after DEN insult. Having confirmed the inflammation 
status, fibrotic injury in our samples, next we assessed HCC markers using 3 complementary strategies: MRI, 
histology and serum markers. First, the T2 weighted MRI scan of alcohol-fed DEN-injected mice showed sig-
nificantly higher number of characteristic intrahepatic biliary cysts visualized as bright spots while the pair-fed 
DEN-injected mice had very few cysts (Fig. 2a). Pixel quantification of these MRI scans using ImageJ revealed 
significantly higher number of nodules in alcohol-fed DEN-injected mice compared to the pair-fed plus DEN 
group (Fig. 2b). Nodules were not found in pair-fed saline-injected and alcohol-fed saline-injected mice.
Second, histopathology examination of the liver sections independently confirmed the presence of intrahe-
patic biliary cysts and hepatic hyperplastic nodules in alcohol-fed DEN-injected mice (Fig. 2c). In addition to 
higher number of intrahepatic biliary cysts, the alcohol-fed DEN-injected mice exclusively showed hepatic hyper-
plastic nodules pointing towards the role of alcohol as a tumor promoter. Quantification of the cysts and nodules 
in liver sections revealed significantly higher number of cysts and nodules, respectively, in livers after chronic 
alcohol plus DEN injection compared to any other experimental groups (Fig. 2c).
Third, serum AFP levels were significantly higher in alcohol-fed DEN-injected mice as compared to pair-fed 
DEN-injected and alcohol-fed saline-injected mice (Fig. 2d). Taken together, the MRI, histopathology, and the 
serum AFP data provided evidence for increased number of biliary cysts and accelerated development of hepatic 
hyperplasia in mice receiving alcohol plus DEN.
Chronic alcohol induces stemness. Two recent independent studies suggested that cancer growth is 
mediated by a small population of stem-like cells, referred to as cancer stem cells (CSCs) or tumor initiating 
cells (TICs) that are characterized by expression of two stem cell markers, CD133 and nanog17,18. In our model, 
expression of CD133 and nanog was significantly higher in alcohol-fed DEN-injected mice compared to pair-fed 
DEN-injected or alcohol-fed saline-injected mice (Fig. 3a). CD133+ liver tumor initiating cells have been shown 
to promote tumor growth via IL-8/CXCL1 signaling in humans17. Expression of CXCL1 was significantly higher 
in alcohol-fed DEN-injected mice suggesting that CXCL1 signaling may be involved in promoting tumor growth 
in this experimental model (Fig. 3a).
The expression of AFP is directly associated with hepatocyte differentiation19. Immunohistochemistry 
staining showed an abundance of AFP positive cells in alcohol-fed DEN-injected mice compared to all other 
groups (Fig. 3b). Bipotent progenitor cells or stem cells within the liver, termed as oval cells, are implicated in 
the pathogenesis of hepatocellular carcinoma and cholangiocarcinoma in animal models and may be important 
in the development of hepatocellular carcinoma in human chronic liver diseases20. In addition, oval cells can 
also directly de-differentiate from mature liver cells such as hepatocytes21. These oval cells have been reported 
to express dual lineage markers, such as alphafetoprotein (AFP) as hepatocyte marker22 and cytokeratins 7 and 
19 as markers of bile duct epithelium23. Immunostaining for CK7 and CK19 revealed increased number of these 
by TBARS assay. (e) Representative Sirius Red staining images from all experimental groups. Bars inside the 
images indicate 100 μ m. (f) For quantification, at least 3 different microscope fields at 10x magnification were 
scored for each mouse (n ≥ 5mice per group). Bar graph shows percent Sirius red positive area quantified using 
ImageJ. (g) Fold changes in mRNA levels of fibrosis markers in liver tissue. In all graphs, values are given as 
average ± SD, ANOVA and Dunnett’s multiple comparison were used to compare the means of multiple groups; 
(*p < 0.05).
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markers of biliary progenitors (CK7 positive cells) and hepatic stem cells or oval cells (CK19 positive cells) in the 
livers of alcohol-fed DEN-injected mice, respectively (Fig. 3c,d).
Figure 2. Alcohol accelerates HCC development after DEN insult. (a) T2-weighted MRI of liver in coronal 
section. Arrows denote cysts. (b) Quantification of cyst area using ImageJ. (c) Representative H & E stained liver 
sections from all treatment groups. Bars inside the images indicate 100 μ m. Biliary cysts were observed in both 
DEN-injected groups while the hepatic hyperplasia (encircled in black dotted line) was exclusively observed 
in alcohol + DEN mice. Bar graph shows average number of biliary cysts and hepatic hyperplastic nodules 
counted at 10× magnification for each mouse (n ≥ 5 mice per group). (d) Fold changes in serum AFP levels. In 
all graphs, values are given as average ± SD, ANOVA and Dunnett’s multiple comparison were used to compare 
the means of multiple groups; (*p < 0.05).
www.nature.com/scientificreports/
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Figure 3. Chronic alcohol induces stemness. (a) Fold changes in mRNA levels of stem cell markers in liver 
tissue (n ≥ 5 mice per group). (b) Representative immunostaining images for AFP showing more positive cells 
in alcohol + DEN mice, (c) CK7 and (d) CK19, respectively. Bars in (b–d) indicate 10 μ m. In all graphs in panel 
(a) values are given as average ± SD, ANOVA and Dunnett’s multiple comparison were used to compare the 
means of multiple groups; (*p < 0.05).
www.nature.com/scientificreports/
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Figure 4. Chronic alcohol up-regulates proliferation, EMT markers. (a) Liver mRNA and protein levels 
of cyclin D1 and p53. β -tubulin and GAPDH used as loading controls for western blots. Relative density of 
signal is shown for each protein blot. (b) Representative immunostaining images for BrdU incorporation. 
Arrows point to positive staining. BrdU positive nuclei were scored in at least 3 different microscopic fields for 
each mouse. Bars indicate 10 μ m. (n ≥ 5 mice per group). (c) Liver mRNA and protein levels of vimentin with 
relative density of vimentin protein. GAPDH used as loading control for western blots. Liver mRNA levels of 
N-cadherin and E-cadherin. In all graphs, values are given as average ± SD, ANOVA and Dunnett’s multiple 
comparison were used to compare the means of multiple groups; (*p < 0.05).
www.nature.com/scientificreports/
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Chronic alcohol up-regulates hepatocyte proliferation and Epithelial Mesenchymal Transition 
(EMT). First, we evaluated the expression of cyclin D1 and p53, signature molecules implicated in HCC pro-
gression24. As shown in Fig. 4a, the expression of both cyclin D1 and p53 was significantly higher in alcohol-fed 
DEN-injected mice at the mRNA and protein levels compared to all other groups (Fig. 4a). To provide evidence 
of cell proliferation, we injected the mice with bromodeoxyuridine (BrdU), the S phase marker before sacrifice. 
As shown in Fig. 4b, higher number of cells was stained BrdU positive in alcohol-fed DEN-injected mice (Fig. 4b).
HCC development is characterized by epithelial mesenchymal transition (EMT)25. Consistent with this, the 
epithelial mesenchymal transition markers, N-cadherin and vimentin, were significantly up-regulated at the 
mRNA level in alcohol-fed DEN-injected mice (Fig. 4c). Up regulation of vimentin in alcohol-fed DEN-injected 
mice was also seen at the protein level (Fig. 4c). Loss of E-cadherin has been shown to promote liver carcinogen-
esis26. The expression of E-cadherin was significantly reduced in alcohol-fed DEN-injected mice as compared to 
alcohol-fed saline-injected and pair-fed DEN-injected mice (Fig. 4c).
Chronic alcohol induces hedgehog signaling. Progression of hepatobilliary cancer involves activa-
tion of multiple intracellular regulatory pathways7. We analyzed the hedgehog (Hh) signaling, a major signa-
ling pathway reported to be dysregulated in HCC27. Upon activation of the surface receptor PTCH1/2 by Hh 
ligands, downstream transcription factors Gli1/2/3 are activated which drive the expression of several Hh tar-
get genes including Cyclin D2, OPN and CD44. The expression of Gli1 was significantly higher in alcohol-fed 
DEN-injected mice as compared to alcohol-fed saline-injected or pair-fed DEN-injected mice (Fig. 5a). Hh tar-
gets, CCND2, OPN and CD44 were significantly up-regulated affirming the activation of Hh pathway in this 
model (Fig. 5b). Sonic hedgehog (Shh), the ligand for Hh pathway showed significant protein induction in liver 
from alcohol-fed DEN-injected mice (Fig. 5c). These data suggest that alcohol alters the expression of Hh target 
genes and dysregulates Hh signaling contributing to progression of HCC.
Figure 5. Up-regulation of hedgehog signaling in experimental HCC model. (a) Liver mRNA levels of Gli-
1. (b) Liver mRNA levels of hedgehog target genes, Ccnd2 (cyclinD2), Opn (osteopontin) and CD44. (c) Liver 
protein levels of Shh, the ligand for hedgehog pathway with relative band intensity. In all graphs, values are 
given as average ± SD, ANOVA and Dunnett’s multiple comparison were used to compare the means of multiple 
groups; (*p < 0.05).
www.nature.com/scientificreports/
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Altered liver microRNA-122 and HIF-1α correlates with HCC in mice. MicroRNAs are small 
non-coding RNA molecules that regulate post transcriptional gene expression via RNA silencing. miRs have 
been reported to control the liver tumor development and aggressiveness28. The most abundant miRNA in the 
liver is miR-122. Decreases in liver tissue miR-122 have been correlated with gain of metastatic properties of liver 
cancer and increased mortality29. We found that the expression of miR-122 in the liver tissue was significantly 
lower in alcohol-fed DEN-injected mice compared to any other groups in this study (Fig. 6a). miR-122 regulates 
the expression of cyclin G1, whose high levels have been reported in several human cancers30. In addition, by 
modulating cyclin G1, miR-122 influences p53 protein stability and transcriptional activity and reduces invasion 
capability of HCC-derived cell lines31. We observed an up-regulation of cyclin G1 (Fig. 6b) and p53 (Fig. 4a) in 
Figure 6. Altered microRNA-122 and HIF-1α expression in liver confirms HCC in mice. (a) miR-122 levels 
in liver. (b) Targets of miR-122, Ccng1 (cyclinG1) and Bcl-w mRNA in liver. (c) Liver HIF-1α mRNA levels, 
HIF-1α DNA binding activity assayed by EMSA and target gene Vegfr1 mRNA levels (n ≥ 5 mice per group). In 
all graphs, values are given as average ± SD, ANOVA and Dunnett’s multiple comparison were used to compare 
the means of multiple groups; (*p < 0.05).
www.nature.com/scientificreports/
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the liver. Bcl-w, an anti-apoptotic gene and a target of miR-122, was significantly up-regulated in alcohol-fed 
DEN-injected mice (Fig. 6b).
Tumor tissues are often characterized by low levels of tissue oxygen known as hypoxia, which makes tumor 
tissues resistant to radiotherapy32. Hypoxia induces the transcription factor HIF-1α which drives the expression 
of various cell proliferation and angiogenesis genes33. We recently discovered that HIF-1α is a miR-122 target34. 
Indeed, alcohol-fed DEN-injected mice showed an up-regulation in HIF-1α mRNA and a remarkable increase in 
its DNA binding activity compared all other groups (Fig. 6c). The expression of VEGFR1, a HIF-1α target gene 
which plays pivotal a role in angiogenesis, was also significantly higher in alcohol-fed DEN-injected mice indicat-
ing an up regulation in the biological activity of HIF-1α (Fig. 6c).
Serum miR-122 increase correlates with liver injury and tumor markers. Circulating microRNAs 
have a potential to serve as biomarkers of disease35. Levels for circulating miR-122 can be useful in predicting 
liver diseases such as HCC and ongoing liver injury36. Hence, we analyzed expression of miR-122 in serum col-
lected at sacrifice from mice. Serum miR-122 levels were highly increased in alcohol-fed DEN-injected mice 
compared to all other groups (Fig. 7a) and showed a positive correlation with ALT increase (Fig. 7b) and serum 
AFP (Fig. 7c). Lastly, a significant correlation was seen between serum miR-122 and CD133 expression (Fig. 7d). 
Taken together, our data provides experimental evidence for alcohol accelerating DEN initiated development of 
HCC in mice.
Discussion
Chronic alcohol use by itself leads to fatty liver, liver inflammation, and cirrhosis37. Epidemiological data sug-
gests that chronic heavy alcohol consumption is a significant risk factor towards the development of HCC4. In 
Figure 7. Up-regulation of serum miR-122 co-relates with liver injury markers. (a) Serum miR-122 levels. 
(b–d) Spearman co-relation of serum miR-122 with serum ALT, serum AFP and liver CD133 respectively. In all 
graphs, values are given as average ± SD, ANOVA and Dunnett’s multiple comparison were used to compare the 
means of multiple groups; (*p < 0.05).
www.nature.com/scientificreports/
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this study we demonstrate that chronic alcohol feeding in adult mice accelerated DEN (chemical) induced liver 
tumor development with molecular characteristics of HCC. We found that features of human alcoholic hepatitis; 
inflammation and fibrosis were increased in DEN-injected mice after alcohol feeding and resulted in increased 
numbers of biliary cysts and early HCC. Our experiments dissected molecular mechanisms involved in early 
hepatic carcinogenesis and found that markers of stemness (CD133 and nanog), factors involved in epithelial 
mesenchymal transition (vimentin and hedgehog activation) and miR-122 decrease, were all present in livers with 
early liver tumors triggered by alcohol plus DEN. Our data indicate that increased progenitor cell activation is 
triggered in the alcoholic liver tissue microenvironment that is characterized by high levels of pro-inflammatory 
signals from both innate (TNFα and MCP-1), adaptive immunity (Th17) and activation of HIF-1α . In addition 
to steatohepatitis induced by chronic alcohol administration, liver fibrosis was also present as indicated by Sirius 
Red staining, alpha-smooth muscle actin and collagen deposition in the liver (Fig. 8).
Although several carcinogen initiated HCC animal models have been described, none of them employed 
alcohol as a dietary component or tumor promoting agent8. A recent study performed in neonate mice com-
bined chronic alcohol exposure in the drinking water with DEN injection and showed tumors at 48 weeks10. 
However, alcohol administration in the drinking water does not cause alcoholic liver disease11. In our current 
study, we employed the Lieber-DeCarli alcohol feeding model that results in features of human alcoholic liver 
disease including steatosis, inflammation and liver fibrosis38,39. By utilizing adult mice and the Lieber-DeCarli 
diet, our model displays the natural course of progression of alcoholic liver disease as well as hyperplastic changes 
as shown by histology and modulation of molecular markers suggestive of early hepatic tumors in a short time 
(12 weeks). However, because of the relatively short alcohol administration, our model cannot provide a direct 
evidence of alcohol increasing liver cancer and a longer follow up will be required to overcome this limitation. 
Nonetheless, our model resembles the human condition of carcinogen pre-exposure followed by long term alco-
hol consumption with features of human alcoholic liver disease and liver fibrosis.
DEN is metabolized in the liver by Cyp2E1, the same enzyme that metabolizes alcohol40. It has been proposed 
that the charged nucleophilic intermediates of DEN attack DNA bases thereby leading to mutations which initiate 
cellular transformation9. Alcohol metabolites also generate ROS, cause inflammation and steatosis. The combined 
effect of these two can lead to hepatocyte transformation (Fig. 8). Because both DEN and alcohol are primarily 
metabolized in hepatocytes, the chronic alcoholic injury may accelerate hepatocyte transformation leading to 
Figure 8. Proposed pathogenic model for alcoholic hepatitis accelerated hepatobiliary cancer.  
Chronic alcohol exposure leads to increased ROS, inflammation and fibrosis which leads to cellular hypoxia 
and proliferation and accelerates the carcinogen induced progression of hepatobiliary cancer. The hepatobiliary 
cancer is characterized by loss of miR-122 and up regulation of its targets cyclinG1 and Bcl-W, increased 
stemness, progenitor cell markers and enhanced EMT.
www.nature.com/scientificreports/
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appearance of early neoplastic foci found in alcohol plus DEN mice only. We confirmed increased reactive oxygen 
species (ROS) in alcohol plus DEN mice as indicated by elevated TBARS. Chemical carcinogens exert their effect 
by generating ROS during their metabolism in the liver, which is responsible for DNA damage associated with 
increased risk of cancer development41. Sustained increased ROS can activate a variety of transcription factors 
including NF-κ B, p53, HIF-1α , β -catenin/Wnt, and Nrf2 in liver leading to chronic inflammation that is respon-
sible for cancer progression42. Our data suggests that in this experimental model, hepatocytes from alcohol plus 
DEN mice are exposed to higher levels of ROS than pair-fed DEN-injected hepatocytes, which may contribute to 
their accelerated transformation to tumors.
DEN induced cancer models in animals show the occurrence of biliary cysts, which has been attrib-
uted to oxidative stress in the liver43. Biliary cysts are known precursors for cholangiocarcinoma (CCA)44. 
Cholangiocarcinoma is the second most common primary hepatic malignancy with 5-year survival rate below 
5%45. Further, alcoholic liver disease has been shown to be an established risk factor for CCA46. Biliary cysts were 
observed in all DEN-injected groups in our experimental model. However, mice receiving both alcohol and DEN 
showed both hepatic hyperplasia and biliary cysts. Cellular transformation of hepatic and biliary progenitors 
points towards the role of alcohol as tumor promoting agent for both hepatocyte and cholangiocyte (biliary epi-
thelial) cell lineages.
The well accepted theory in cancer biology states that cancer originates from a small number of cancer 
stem cells (CSCs) or tumor initiating cells (TICs)47. These cells express unique stem cell markers which are not 
expressed by their adult differentiated counterparts. This small population of CSCs is able to extract more nutri-
ents from the blood stream and proliferate faster48. We report significant up-regulation in AFP and CK19 both, 
markers of oval cells which are bipotent precursor cells in the liver that can contribute to the formation of hepat-
ocytes as well as bile ducts22,23 and have been implicated in development of HCC and CCA20. However, recently 
it was shown that oval cells can also de-differentiate directly from mature liver cells such as hepatocytes21. Hence, 
the precise origin of these oval cells in our experimental model remains uncertain. A time course or in vivo cell 
lineage tracing study will help to ascertain the origin of these oval cells. Interestingly, adult murine liver oval cell 
population has been shown to express CD133, another stem cell marker49. CD133 and Nanog have been useful 
in identifying this CSC population in HCC17,18. The significant increase in liver CD133 and nanog of alcohol-fed 
DEN-injected mice suggests a synergistic effect of alcohol and DEN on the HCC cancer stem cells. Further, the 
CD133/CXCL1 pathway is shown to be up-regulated in human HCC17, whereas TGFβ can induce EMT transi-
tion and stem cell properties in CCA50. Given the highly elevated CXCL1 and TGFβ in alcohol plus DEN mice, 
a combination of both these may accelerate development of hepatobiliary cancer in our model. The presence of 
multiple well established stem cell makers (CD133, nanog, AFP, CK7, and CK19) provides strong evidence to the 
involvement of oval cells in development of HCC in this model. DEN pre-exposure could selectively up-regulate 
CK19 in oval cells and alcohol may accelerate the proliferation of these cells to the mixed phenotype of hepato-
biliary cancer seen in our model. Tumor tissue is often characterized by up-regulation of proliferation markers. 
In addition, tumor tissue overexpresses EMT markers which are useful in hyperproliferation and angiogenesis. 
Loss of E-cadherin and up-regulation of N-cadherin along with induction of CCND1 are direct indicators of 
hyperproliferative hepatobiliary cells in alcohol plus DEN mice26.
Additional evidence of accelerated HCC development by alcohol is up-regulation of the Hedgehog (Hh) path-
way in our model. Hh plays an important role in the development of tissues and is highly active during early 
stages of life27.The transcription factors associated with Hh signaling control the expression of several proteins 
important in cell cycle, cell differentiation and maturation27. Treatment with Hh antagonist is reported to pro-
mote regression of HCC in murine model51. Upon binding of Hh ligand to its receptor PTCH1, a seven mem-
brane spanning receptor Smoothened (Smo) activates the downstream transcriptional cascade via Gli proteins. 
Using purmorphamine, an agonist of Smo, Gores et al. discovered the role of non-canonical Hh signaling in 
CCA52. The up-regulation of Gli-1, Hh target genes and the ligand Shh in alcohol plus DEN mice suggest that Hh 
pathway may drive the progression of the mixed phenotype of HCC and CCA in our experimental model.
The most abundant miRNA in the liver is miR-122. miR-122 expression increases during embryogenesis 
until it constitutes 72% of total miRNA in adult human liver53. However, decrease in hepatic miR-122 is known 
to be a tumor-specific event in humans54 as well as experimental animal models53. Anti-inflammatory and 
anti-tumorigenic role for hepatic miR-122 has been reported55. Further, loss of tissue miR-122 expression in 
liver cancer has been reported to correlate with gain of metastatic properties29. Consistent with this, we found 
decreased liver miR-122 and increased expression of molecular markers of HCC in DEN plus alcohol treated 
mice. Overexpression of miR-122 reduces tumorigenic properties in HCC cell lines56 and recent reports propose 
a unique therapeutic potential for miR-122 in liver diseases57. A number of validated miR-122 targets includ-
ing cyclin G1, ADAM10, IGF1R, SRF, ADAM17 and Wnt1 are shown to be involved in hepatocarcinogenesis, 
epithelial-mesenchymal transition, and angiogenesis31,56,58. Our lab has recently shown that microRNA-122 reg-
ulates HIF-1α in hepatocytes in a diet-induced steatohepatitis model34. Hypoxia induced HIF-1α , a well studied 
transcription factor in cancer models, plays a pivotal role in advancement of tumor59. Interestingly, chronic alco-
hol is also known to induce HIF-1α expression and activity in the liver60. Thus, the hepatic HIF-1α activity may 
be under dual regulation in our model. Up-regulation of HIF-1α DNA binding activity and VEGFR1 mRNA in 
our experimental model upholds a role for miR-122 regulated HIF-1α in HCC development and progression.
Circulating miRs have been reported for their potential as biomarkers of drug induced liver injury35 as well as 
NASH61. Recent reports found that the change in plasma miR-122 concentration precedes the increase in ami-
notransferase activity in the blood, making it one of the earliest markers of liver injury62. Circulating miR-122 has 
been reported as a novel potential biomarker for diagnosis of different types of liver diseases including HCC35,57,63. 
Serum miR-122 was elevated in patients with HCC or chronic hepatitis64. A correlation of serum miR-122 with 
clinical chemistry parameters of liver injury, hepatic necro-inflammation is known and therefore use of serum 
miR-122 levels as prognostic markers in patients with hepatocellular carcinoma is suggested36. Our experimental 
www.nature.com/scientificreports/
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data here shows a significant increase in serum miR-122 with a concurrent loss of miR-122 in the liver tissue thus 
acknowledging the proposed the role for miR-122 as a HCC biomarker in animal models. We found a significant 
positive correlation of serum miR-122 levels with established clinical markers of liver injury, ALT, serum AFP 
and histology.
In summary, by combining multiple DEN injections prior to chronic Lieber-DeCarli alcohol diet feeding, we 
have developed a mouse model that displays the features of hepatobiliary tumor. Our model involves a sequen-
tial step-wise progression of alcoholic liver disease to hepatobililary cancer with molecular signatures of HCC 
(Fig. 8). Importantly, our model involves mice with alcoholic steatohepatitis and has all the features usually asso-
ciated with pathogenesis and diagnosis of human HCC. This combination presents one of the most unique phe-
nomenons of chronic alcohol leading to progression of HCC that occurs in humans. In our opinion, availability 
of such a model will enable testing anti-cancer drugs in preclinical setup as well as provide opportunities to 
understand alcohol associated molecular and cellular mechanisms related to HCC.
Methods
Animal model of hepatobiliary carcinoma. To establish a mouse model of hepatobiliary cancer based 
on Lieber-DeCarli alcohol diet, we injected 4 week old C57bl/6 male mice with total 6 doses of DEN (Sigma, St. 
Louise, MO) intraperitoneally. As shown in supplementary Fig. S1, a dose of 75 mg/kg DEN was administered 
weekly for first 3 weeks and for later 3 weeks a dose of 100 mg/kg DEN was injected i.p. At week 8, the mice 
were divided into alcohol and pair-fed (control) groups. Two age matched groups of mice without DEN were 
included in the study to understand the effect of chronic alcohol feeding (Supplementary Fig. S1). Depending 
on the experimental design, mice were fed 4% Lieber-Decarli alcohol diet or calorie matched control diet for 6 
weeks. At sacrifice, blood and liver tissues were collected for further assays. The study protocol was approved by 
the Institutional Animal Use and Care Committee of the University of Massachusetts Medical School. All the 
methods were carried out in accordance with the approved guidelines.
Magnetic Resonance Imaging. Magnetic resonance imaging (MRI) of liver was performed to monitor 
hyperplastic changes in liver. Images were obtained using 3T Philips Achieva whole-body MR scanner (Philips 
Medical Systems, Best, Netherlands) with a custom-made solenoid T/R coil with a diameter of 30 mm. The ani-
mals were anesthetized with 5% isoflurane mixed with carbogen (95% O2/5% CO2) and were maintained with 1% 
to 2% isofluorane. Coronal T2–weighted spin echo images were acquired with respiratory triggering to reduce 
the motion artifacts. The respiration rate was monitored with an optical probe (Model 1025 T Monitoring and 
Gating System, SA Instruments Inc, Stony Brook, NY). The output signal from the respiration monitor was used 
to trigger, in real time, the MR acquisition. As a consequence of the triggered acquisition, the TR value of around 
2000 ms, corresponding to the respiration rate of around 30 bpm, was determined. Other imaging parameters 
were: echo time (TE) of 70 ms, flip angel of 90 degrees, TSE-factor of 8, number of average = 4, matrix size of 
148 × 120, field of view of 30 × 25 mm2, slice thickness of 1 mm with no gap, acquisition time around 4 mins for 
22 slices. Hyperplastic nodules were distinguished from normal liver tissues on basis of differences in homogene-
ity and signal intensity. Pixel based nodule area quantitation was performed using ImageJ software.
Biochemical Assays and cytokines. Serum alanine aminotransferase (ALT) activity was determined 
using a kinetic method (TECO Diagnostics, Anaheim, CA). Intracellular cytokine levels were monitored in liver 
whole cell lystate using TNFα , IL-6, MCP-1 ELISA kits (Biolegend, San Diego, CA). Liver thiobarbituric acid 
reactive substances (TBARS), a measure of oxidative stress, were estimated using TBARS assay kit (ZeptoMetrix, 
Buffalo, NY). Tissue IL-17 and serum AFP were assayed by ELISA (R&D systems, Minneapolis, MN).
EMSA. The DNA binding activity of HIF-1α was assessed by electrophoretic mobility shift assay as described 
previously60. Briefly, nuclear protein extract from liver (5 μ g) was incubated with 50,000 cpm γ 32P-labeled HIF-1α 
consensus oligonucleotide at room temperature for 30 min. All reactions were run on a 4% polyacrylamide gel, 
and the dried gel was exposed to an X-ray film at − 80 °C for different times. For the cold competition reaction, 
a 20-fold excess of same, unlabeled, double-stranded oligonucleotide was added to the reaction mixture before 
adding the labeled oligonucleotide probe.
RNA extraction and real-time PCR. Total RNA was extracted using the Direct-zol RNA MiniPrep accord-
ing to the manufacturer’s instructions (Zymo Research, Irvin, CA). RNA was quantified using Nanodrop 2000 
(Thermo Scientific, Wilmington, DE). Complementary DNA (cDNA) synthesis was performed by reverse tran-
scription of total RNA using the iScript Reverse Transcription Supermix (BIO-RAD, Hercules, CA). Real-time 
quantitative PCR was performed using the CFX96 real-time detection system (Bio-Rad Laboratories, Hercules, 
CA). Primers were synthesized by IDT, Inc. (Coralville, IA). The primer sequences are listed in Table 1 below. 
Accumulation of PCR products was detected by monitoring the increase in fluorescence of double-stranded 
DNA-binding dye SYBR Green during amplification. Relative gene expression was calculated by the comparative 
cycle threshold (Ct) method. The expression level of target genes was normalized to the house-keeping gene, 
18S rRNA, in each sample and the fold-change in the target gene expression between experimental groups was 
expressed as a ratio. Melt-curve analysis was used to confirm the authenticity of the PCR products.
miRNA Analysis. Tissue samples were lysed in QIAzol Lysis reagent (Qiagen, Maryland, USA), homogenized 
with stainless steel beads in TissueLyser II (Qiagen, Maryland, USA) and incubated on ice for five minutes fol-
lowed by miRNA isolation using Direct-zol RNA MiniPrep kit with on column DNase digestion (Zymo Research, 
Irvin, CA). Reverse transcription (30 min − 16 °C; 30 min − 42 °C; 5 min − 85 °C) was performed in Eppendorf 
Mastercycler (Eppendorf, New York, USA) using 10 ng RNA, TaqMan primers and MiRNA Reverse Transcription 
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Kit (Applied Biosystems, Foster City, CA), followed by quantitative RT-PCR (10 min − 95 °C; 40 cycles of 15 sec 
− 95 °C; 1 min − 60 °C) in CFX96 (Bio-Rad Laboratories, Hercules, CA) using TaqMan Universal PCR Master 
Mix (Biorad, Hercules, CA). All tissue results were normalized to snoRNA202 expression. Serum sample controls 
were spiked with Caenorhabditis elegans (cel)-miR-39, as per instructions (Qiagen, Gaithersburg, MD) and sub-
sequently analyzed utilizing a primer pool. Briefly, serum cDNA synthesis was performed with a final 0.1x primer 
concentration and Applied Biosystems’s rtPCR kit followed by individual target-specific RT-qPCR analysis using 
Bio-Rad iTaq Universal Probes Master Mix according to manufacturer instructions.
Western blot analysis. Whole cell lysates, nuclear and cytoplasmic extracts were prepared from mouse 
livers as described previously60. Proteins of interest were detected by immunoblotting with specific primary anti-
bodies against: cyclin D1 (SC-753; santacurz), p53 (ab28; abcam), vimentin (ab92547; Abcam), Shh (SC-9024, 
Santa Cruz), β -tubulin-HRP (ab185057; Abcam), GAPDH-HRP (ab9482; Abcam). Respective horseradish per-
oxidase–labeled secondary antibodies were from Santacruz Biotechnology (Dallas, TX). The specific immuno-
reactive bands of interest were detected by chemiluminescence (Bio-Rad, Hercules, CA). The immunoreactive 
bands were quantified by densitometric analysis using the UVP System (Bio-Rad Laboratories, Hercules, CA).
Histopathological analysis. Sections of formalin-fixed, paraffin-embedded livers were stained with 
hematoxylin and eosin (H&E), or Sirius Red and assessed for histological features of carcinoma and fibrosis. 
The H&E stained sections were independently examined by a veterinary pathologist, Dr. Garlick in a blinded 
manner (see acknowledgments). The quantitation of Sirius Red staining was performed using ImageJ software. 
Immunohistochemistry staining for AFP (ab46799; Abcam), CK7 (ab9021; Abcam), CK19 (ab52625; Abcam), 
was performed on formalin-fixed, paraffin-embedded livers according to the manufacturer’s instructions. To 
examine cell proliferation, mice were injected i.p. with 100 mg/kg BrdU (Sigma, St. Louise, MO) 2 hr prior to 
sacrifice, and paraffin sections were stained using the anti BrdU antibody (ab6326, Abcam). ImageJ (NIH) was 
used for image analysis.
Statistical Analysis. Statistical significance was determined using two – tailed t-test; two-way ANOVA and 
Dunnett’s multiple comparison post-test were used to compare the means of multiple groups. Data are shown as 
mean ± SD and were considered statistically significant at p < 0.05. GraphPad Prism 6.02 (GraphPad Software 
Inc., La Jolla, CA) was used for analysis.
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